Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helmut Deissler

Showing results (41-50 of 63) with videos related to

Pageof 7
Sort By:
International Journal of Cancer|October 19, 2017
A low-frequency haplotype spanning SLX4/FANCP constitutes a new risk locus for early-onset breast cancer (<60 years) and is associated with reduced DNA repair capacityHarald Surowy, Dominic Varga, Barbara Burwinkel, et al.
Human Mutation|May 28, 2011
Germline mutations in the PALB2 gene are population specific and occur with low frequencies in familial breast cancerHeide Hellebrand, Christian Sutter, Ellen Honisch, et al.
International Journal of Cancer|April 13, 2011
Association of death receptor 4 variant (683A > C) with ovarian cancer risk in BRCA1 mutation carriersMichelle G Dick, Beatrix Versmold, Christoph Engel, et al.
International Journal of Cancer|October 27, 2009
Low-risk variants FGFR2, TNRC9 and LSP1 in German familial breast cancer patientsKari Hemminki, Bertram Müller-Myhsok, Peter Lichtner, et al.
Nature Genetics|April 20, 2010
Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility geneAlfons Meindl, Heide Hellebrand, Constanze Wiek, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 28, 2010
Association of the variants CASP8 D302H and CASP10 V410I with breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriersChristoph Engel, Beatrix Versmold, Barbara Wappenschmidt, et al.
Breast Cancer Research : BCR|December 1, 2010
Evidence for SMAD3 as a modifier of breast cancer risk in BRCA2 mutation carriersLogan C Walker, Zachary S Fredericksen, Xianshu Wang, et al.
American Journal of Human Genetics|November 14, 2007
RAD51 135G-->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studiesAntonis C Antoniou, Olga M Sinilnikova, Jacques Simard, et al.
American Journal of Human Genetics|March 22, 2008
Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriersAntonis C Antoniou, Amanda B Spurdle, Olga M Sinilnikova, et al.
Human Genetics|May 21, 2011
Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriersKate M Im, Tomas Kirchhoff, Xianshu Wang, et al.
Pageof 7

Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
International Journal of Cancer|October 19, 2017
A low-frequency haplotype spanning SLX4/FANCP constitutes a new risk locus for early-onset breast cancer (<60 years) and is associated with reduced DNA repair capacityHarald Surowy, Dominic Varga, Barbara Burwinkel, et al.
Human Mutation|May 28, 2011
Germline mutations in the PALB2 gene are population specific and occur with low frequencies in familial breast cancerHeide Hellebrand, Christian Sutter, Ellen Honisch, et al.
International Journal of Cancer|April 13, 2011
Association of death receptor 4 variant (683A > C) with ovarian cancer risk in BRCA1 mutation carriersMichelle G Dick, Beatrix Versmold, Christoph Engel, et al.
International Journal of Cancer|October 27, 2009
Low-risk variants FGFR2, TNRC9 and LSP1 in German familial breast cancer patientsKari Hemminki, Bertram Müller-Myhsok, Peter Lichtner, et al.
Nature Genetics|April 20, 2010
Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility geneAlfons Meindl, Heide Hellebrand, Constanze Wiek, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 28, 2010
Association of the variants CASP8 D302H and CASP10 V410I with breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriersChristoph Engel, Beatrix Versmold, Barbara Wappenschmidt, et al.
Breast Cancer Research : BCR|December 1, 2010
Evidence for SMAD3 as a modifier of breast cancer risk in BRCA2 mutation carriersLogan C Walker, Zachary S Fredericksen, Xianshu Wang, et al.
American Journal of Human Genetics|November 14, 2007
RAD51 135G-->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studiesAntonis C Antoniou, Olga M Sinilnikova, Jacques Simard, et al.
American Journal of Human Genetics|March 22, 2008
Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriersAntonis C Antoniou, Amanda B Spurdle, Olga M Sinilnikova, et al.
Human Genetics|May 21, 2011
Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriersKate M Im, Tomas Kirchhoff, Xianshu Wang, et al.
Pageof 7